兽医氧疗市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球兽医氧气治疗市场价值为 12 亿美元，预计到 2034 年将以 8.5% 的复合年增长率成长，达到 27 亿美元。这一成长趋势反映了兽医医疗保健的重大转变，因为氧气治疗已成为治疗患有呼吸系统疾病和慢性疾病的宠物的核心组成部分。人们对宠物健康的认识不断提高，宠物的人性化程度不断提高，以及宠物主人愿意花钱购买先进治疗方案的意愿不断增强，这些都加强了兽医环境中对氧疗的采用。肺炎、气喘、慢性阻塞性肺病 (COPD) 和其他呼吸系统併发症等疾病越来越常见，尤其是在污染程度高的城市环境中。兽医护理正在向更患者友好、非侵入性的解决方案转变，氧气治疗已成为术后恢復和重症监护的可靠方法。此外，肥胖相关併发症的盛行率上升以及宠物数量老化也加速了诊所和家庭对持续和紧急氧气支持的需求。

越来越多的兽医院和专科诊所正在采用先进的氧气治疗设备，如浓缩器、鼻导管和高效氧气面罩，以提高存活率并改善治疗效果。术后併发症通常需要氧气治疗才能稳定恢復，这使其成为重症兽医护理的关键部分。技术创新，尤其是便携式氧气浓缩器的引入，显着改善了护理服务。这些设备提供持续的氧气流，使其成为诊所和家庭护理的理想选择，特别是对于慢性病患者。与传统氧气瓶相比，便携式浓缩器更具永续性且维护需求更少，为从业者和宠物主人提供了经济高效的解决方案。

市场按产品类型细分为兽医氧气浓缩器和配件。光是氧气浓缩器领域，2024 年的产值就达 9.845 亿美元。这包括固定式和便携式设备，由于外科手术和紧急呼吸病例的增加，这些设备的使用也越来越广泛。老年宠物常会患肺炎、支气管炎、呼吸窘迫症候群等疾病，而氧气治疗是治疗这些疾病的首选方法。浓缩器的便利性、高效性和环保性使其成为兽医专业人士的首选。

根据动物类型，市场分为小型动物和大型动物，其中小型动物在 2024 年占 60% 的份额。这种主导地位与哈巴狗、斗牛犬和波斯猫等小型宠物的广泛饲养有关，这些宠物容易出现呼吸障碍。在北美，由于强大的宠物医疗基础设施、较高的宠物拥有率以及人们对慢性呼吸系统疾病的认识不断提高，兽医氧疗市场在 2024 年占全球份额的 39.9%。

Imex Medical Limited、AEOLUS International Pet Products、Drive DeVilbiss International、Koninklijke Philips、Vetland Medical、RWD Life Science、Airnetic、Shinova Systems、BMV Animal Technology 和 Longfian Scitech 等领先公司正在塑造市场格局。这些参与者将创新放在首位，并大力投资研发，以推出更便携、更具成本效益和更有效率的氧气治疗系统。他们还与兽医院和诊所建立策略联盟，以加强其服务网络，并推出尖端设备来满足不断变化的兽医护理需求。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物拥有量和兽医护理支出的增加
    • 动物呼吸道和心臟疾病盛行率上升
    • 氧气浓缩器的技术进步
  • 产业陷阱与挑战
    • 兽医氧气治疗设备成本高
    • 发展中地区缺乏意识
• 成长潜力分析
• 监管格局
• 技术格局
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 兽用氧气浓缩器
  • 固定式氧气浓缩器
  • 便携式氧气浓缩器
• 配件

第六章：市场估计与预测：依动物类型，2021 年至 2034 年

• 主要趋势
• 小动物
• 大型动物

第七章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 重症监护
• 居家照护环境/术后护理
• 其他应用

第八章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 兽医院
• 兽医诊所
• 其他最终用途

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• AEOLUS International Pet Products
• Airnetic
• BMV Animal Technology
• CAIRE
• Drive DeVilbiss International
• Imex Medical Limited
• Koninklijke Philips
• Longfian Scitech
• RWD Life Science
• Shinova Systems
• Vetland Medical

The Global Veterinary Oxygen Therapy Market was valued at USD 1.2 billion in 2024 and is estimated to grow at a CAGR of 8.5% to reach USD 2.7 billion by 2034. This growth trend reflects a significant transformation in veterinary healthcare as oxygen therapy becomes a core component in treating pets with respiratory disorders and chronic illnesses. Rising awareness about pet health, the humanization of pets, and increased willingness among pet owners to spend on advanced treatment solutions are reinforcing the adoption of oxygen therapy across veterinary settings. Conditions like pneumonia, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory complications are becoming increasingly common, especially in urban environments where pollution levels are high. Veterinary care is undergoing a shift toward more patient-friendly, non-invasive solutions, with oxygen therapy emerging as a reliable method for post-surgical recovery and critical care. In addition to that, the rising prevalence of obesity-related complications and aging pet populations are accelerating the demand for continuous and emergency oxygen support in clinics and at home.

A growing number of veterinary hospitals and specialty clinics are now incorporating advanced oxygen therapy devices such as concentrators, nasal catheters, and high-efficiency oxygen masks to improve survival rates and enhance treatment outcomes. Post-operative complications often require oxygen therapy for stabilized recovery, making it a critical part of intensive veterinary care. Technological innovations, especially the introduction of portable oxygen concentrators, have significantly improved care delivery. These devices offer continuous oxygen flow, making them ideal for both in-clinic and at-home care, particularly for chronic conditions. Compared to traditional oxygen cylinders, portable concentrators are more sustainable and require less maintenance, offering cost-effective solutions for both practitioners and pet owners.

The market is segmented by product type into veterinary oxygen concentrators and accessories. The oxygen concentrator segment alone generated USD 984.5 million in 2024. This includes both stationary and portable devices, which are being increasingly used due to a rise in surgical interventions and emergency respiratory cases. Aging pets often suffer from ailments such as pneumonia, bronchitis, and respiratory distress syndrome, for which oxygen therapy is the preferred method of care. The convenience, efficiency, and eco-friendliness of concentrators have made them a preferred choice among veterinary professionals.

By animal type, the market is categorized into small and large animals, with the small animal segment accounting for a 60% share in 2024. This dominance is linked to the widespread ownership of small pets like pugs, bulldogs, and Persian cats, which are prone to breathing disorders. In North America, the veterinary oxygen therapy market accounted for 39.9% of the global share in 2024, thanks to strong pet healthcare infrastructure, higher pet ownership rates, and growing awareness of chronic respiratory conditions.

Leading companies such as Imex Medical Limited, AEOLUS International Pet Products, Drive DeVilbiss International, Koninklijke Philips, Vetland Medical, RWD Life Science, Airnetic, Shinova Systems, BMV Animal Technology, and Longfian Scitech are shaping the market landscape. These players are prioritizing innovation and investing heavily in research and development to introduce more portable, cost-effective, and efficient oxygen therapy systems. They are also forming strategic alliances with veterinary hospitals and clinics to enhance their service networks and launching cutting-edge devices to address the evolving needs of veterinary care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership and spending on veterinary care
    • 3.2.1.2 Rising prevalence of respiratory and cardiac diseases in animals
    • 3.2.1.3 Technological advancements in oxygen concentrator
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of veterinary oxygen therapy equipment
    • 3.2.2.2 Lack of awareness in developing regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter’s analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Veterinary oxygen concentrator
  • 5.2.1 Stationary oxygen concentrator
  • 5.2.2 Portable oxygen concentrator
• 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Small animals
• 6.3 Large animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Intensive care
• 7.3 Homecare setting/postoperative care
• 7.4 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals
• 8.3 Veterinary clinics
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AEOLUS International Pet Products
• 10.2 Airnetic
• 10.3 BMV Animal Technology
• 10.4 CAIRE
• 10.5 Drive DeVilbiss International
• 10.6 Imex Medical Limited
• 10.7 Koninklijke Philips
• 10.8 Longfian Scitech
• 10.9 RWD Life Science
• 10.10 Shinova Systems
• 10.11 Vetland Medical